The Joint, headquartered in Scottsdale, Arizona, operates approximately 135 corporate clinics and 800 franchises, employing 444 staff. The company went public on November 11, 2014, offering wellness packages and digital record management.
JYNT has been in the news recently: BioLineRx's GLIX1, which targets glioblastoma, has received FDA clearance for a Phase 1/2a study expected in Q1 2026, with a projected market value exceeding $3.8 billion by 2030. Additionally, Supple Pets LLC has introduced SUPPLE PETS® Hip & Joint Care Chews, utilizing premium ingredients and trusted by over 55 million consumers.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.